Contact us


Home > Investment tools > They choose Russia > Chemical Works of Gedeon Richter Plc.

Chemical Works of Gedeon Richter Plc.

Richter continues to plan expanding its production capacities in Russia, said Erik Bogsch, Chief Executive Officer of Hungary’s leading pharmaceutical producer. 

Setting up and gradual expansion of Richter’s Russian manufacturing plant carries great importance. About 15% of Richter’s sales in Russia are already covered from locally-manufactured products and this ratio is likely to increase further, he added. 

As regards the outlook, Bogsch said international expansion is vital for the company. Whereas Richter needs to keep its profit on generic drug sales it also has to be present on the market of biosimilar products and continue original research in the development of central nervous system drugs too. 

02 September 2014

Investor profile

Chemical Works of Gedeon Richter Plc.


Company's website:

T: +44 (0) 207 604 8800

Public company (RICHTER)


Contact: Erik Bogsch, CEO

Gedeon Richter is the largest biotechnology and pharmaceutical company in Hungary and middle sized globally, presented in nearly 40 countries. 

Subscribe to Newsletters